Evidence map›Paper›PMID 26492382›Full record

ArticleScientific reports2015

Sickle cell detection using a smartphone.

S M Knowlton, I Sencan, Y Aytar, J Khoory, M M Heeney, I C Ghiran, S Tasoglu

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it, 126 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Hemp-Based Microfluidics.Micromachines · 2021
    Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

S M KnowltonDepartment of Biomedical Engineering, University of Connecticut, 260 Glenbrook Road, Storrs, CT 06269.
I SencanDepartment of Diagnostic Radiology, Yale School of Medicine, New Haven, CT 06520-8043.
Y AytarComputer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Vassar Street Cambridge, MA 02139.
J KhooryDepartment of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston MA 02115.
M M HeeneySickle Cell Program, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston MA 02115.
I C GhiranDepartment of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston MA 02115.
S TasogluDepartment of Biomedical Engineering, University of Connecticut, 260 Glenbrook Road, Storrs, CT 06269.
Harvard University · USUniversity of Connecticut · USDana-Farber/Boston Children's Cancer and Blood Disorders Center · USVassar College · USYale University · US

Funding

Modulation of erythrocyte function by complementR01HL096795 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI GHIRAN, IONITA CALIN · 2011 to 2014
$1.7M
Malaria screening in resource-poor settings using a simple, power-free, cell phone-friendly deviceR21TW009915 · FIC · BETH ISRAEL DEACONESS MEDICAL CENTER · PI GHIRAN, IONITA CALIN · 2014 to 2015
$435k
FIC NIH HHS R21 TW009915NHLBI NIH HHS R01 HL096795
6 · The paper itself

Abstract

Sickle cell disease affects 25% of people living in Central and West Africa and, if left undiagnosed, can cause life threatening "silent" strokes and lifelong damage. However, ubiquitous testing procedures have yet to be implemented in these areas, necessitating a simple, rapid, and accurate testing platform to diagnose sickle cell disease. Here, we present a label-free, sensitive, and specific testing platform using only a small blood sample (<1 μl) based on the higher density of sickle red blood cells under deoxygenated conditions. Testing is performed with a lightweight and compact 3D-printed attachment installed on a commercial smartphone. This attachment includes an LED to illuminate the sample, an optical lens to magnify the image, and two permanent magnets for magnetic levitation of red blood cells. The sample is suspended in a paramagnetic medium with sodium metabisulfite and loaded in a microcapillary tube that is inserted between the magnets. Red blood cells are levitated in the magnetic field based on equilibrium between the magnetic and buoyancy forces acting on the cells. Using this approach, we were able to distinguish between the levitation patterns of sickle versus control red blood cells based on their degree of confinement.

Indexed as

SmartphoneAnemia, Sickle CellHumansMobile ApplicationsSensitivity and Specificity

Identifiers

PMID26492382
PMCPMC4615037
OpenAlexW2177045159

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.